Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8241710rdf:typepubmed:Citationlld:pubmed
pubmed-article:8241710lifeskim:mentionsumls-concept:C0003402lld:lifeskim
pubmed-article:8241710lifeskim:mentionsumls-concept:C0018823lld:lifeskim
pubmed-article:8241710lifeskim:mentionsumls-concept:C0032105lld:lifeskim
pubmed-article:8241710lifeskim:mentionsumls-concept:C0027061lld:lifeskim
pubmed-article:8241710lifeskim:mentionsumls-concept:C0041536lld:lifeskim
pubmed-article:8241710pubmed:issue8 Suppllld:pubmed
pubmed-article:8241710pubmed:dateCreated1994-1-4lld:pubmed
pubmed-article:8241710pubmed:abstractTextNine patients who underwent heart transplantation (one female; average age 48 +/- 11, range 19-58 years) were followed in respect to contents of right-sided heart septum, blood and plasma ubiquinone (UQ), plasma alpha-tocopherol (alpha T), and plasma free cholesterol (FC). In contrast to healthy persons, substantial inter- and intraindividual variations were observed; individually low values were seen with rejection. Heart muscle UQ in well-treated patients averaged 0.33 +/- 0.08, range 0.06-0.58 micrograms mg-1 (0.38 +/- 0.09 mumol g-1 dry weight) and was not different from healthy individuals. Plasma UQ, alpha T; and FC averaged 0.63 +/- 0.33 micrograms ml-1 (P < 0.05 versus sedentary controls), 8.1 +/- 4.0 micrograms ml-1 (P < 0.01), and 0.52 +/- 0.23 mg ml-1 (P < 0.05). Corresponding molar values were 0.73 +/- 0.37 (UQ), 2.0 +/- 1.1 mumol l-1 (alpha T), and 1.42 +/- 0.54 mmol l-1 (FC). Blood and plasma UQ values were identical. A saturation like relationship was found between heart and blood UQ:blood contents below 0.7 micrograms ml-1 (0.8 mumol l-1) corresponded to markedly lowered heart contents. In four patients in whom blood samples were taken close to a fatal complication it averaged 0.42 micrograms ml-1 (0.49 mumol l-1, P < 0.01). When low heart muscle and blood ubiquinone were present, other variables such as left ventricle cardiac output or cycle ergometer performance was markedly impaired. Plasma UQ and alpha T covaried with a marker of the lipoidal deposit volume, plasma FC.(ABSTRACT TRUNCATED AT 250 WORDS)lld:pubmed
pubmed-article:8241710pubmed:languageenglld:pubmed
pubmed-article:8241710pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8241710pubmed:citationSubsetIMlld:pubmed
pubmed-article:8241710pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8241710pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8241710pubmed:statusMEDLINElld:pubmed
pubmed-article:8241710pubmed:issn0941-0198lld:pubmed
pubmed-article:8241710pubmed:authorpubmed-author:FolkersKKlld:pubmed
pubmed-article:8241710pubmed:authorpubmed-author:AströmHHlld:pubmed
pubmed-article:8241710pubmed:authorpubmed-author:KarlssonJJlld:pubmed
pubmed-article:8241710pubmed:authorpubmed-author:DiamantBBlld:pubmed
pubmed-article:8241710pubmed:authorpubmed-author:LiskaJJlld:pubmed
pubmed-article:8241710pubmed:authorpubmed-author:SembBBlld:pubmed
pubmed-article:8241710pubmed:authorpubmed-author:KotzSSlld:pubmed
pubmed-article:8241710pubmed:authorpubmed-author:GunnesSSlld:pubmed
pubmed-article:8241710pubmed:issnTypePrintlld:pubmed
pubmed-article:8241710pubmed:volume71lld:pubmed
pubmed-article:8241710pubmed:ownerNLMlld:pubmed
pubmed-article:8241710pubmed:authorsCompleteYlld:pubmed
pubmed-article:8241710pubmed:paginationS76-83lld:pubmed
pubmed-article:8241710pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:8241710pubmed:meshHeadingpubmed-meshheading:8241710-...lld:pubmed
pubmed-article:8241710pubmed:meshHeadingpubmed-meshheading:8241710-...lld:pubmed
pubmed-article:8241710pubmed:meshHeadingpubmed-meshheading:8241710-...lld:pubmed
pubmed-article:8241710pubmed:meshHeadingpubmed-meshheading:8241710-...lld:pubmed
pubmed-article:8241710pubmed:meshHeadingpubmed-meshheading:8241710-...lld:pubmed
pubmed-article:8241710pubmed:meshHeadingpubmed-meshheading:8241710-...lld:pubmed
pubmed-article:8241710pubmed:meshHeadingpubmed-meshheading:8241710-...lld:pubmed
pubmed-article:8241710pubmed:meshHeadingpubmed-meshheading:8241710-...lld:pubmed
pubmed-article:8241710pubmed:meshHeadingpubmed-meshheading:8241710-...lld:pubmed
pubmed-article:8241710pubmed:meshHeadingpubmed-meshheading:8241710-...lld:pubmed
pubmed-article:8241710pubmed:meshHeadingpubmed-meshheading:8241710-...lld:pubmed
pubmed-article:8241710pubmed:meshHeadingpubmed-meshheading:8241710-...lld:pubmed
pubmed-article:8241710pubmed:year1993lld:pubmed
pubmed-article:8241710pubmed:articleTitleHeart muscle ubiquinone and plasma antioxidants following cardiac transplantation.lld:pubmed
pubmed-article:8241710pubmed:affiliationDepartment of Clinical Physiology, Karolinska Institute, Stockholm.lld:pubmed
pubmed-article:8241710pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8241710lld:pubmed